Back to Results

Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (CORZW)

-


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Next Earnings Date Market Cap Free Float / Shares Outstanding
NASDAQ-CORZW
Not available
Not available
Not available
Weak
November 2, 2026
4.21 B
91.1%
Valuation • Fair Value

Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW) Fair Value by Valuation Model

No usable valuation estimate is currently available for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

440.3 M

Current operating scale indicator.

Revenue Forecast

661.1 M

Forward revenue estimate.

EBITDA

-78.245 M

Current operating profitability reference.

EBITDA Forecast

227.6 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW)

Review the upcoming company dates currently supported by the latest data.

Next Earnings Date

November 2, 2026

Days to Earnings

9

How to read events and dividends

Track the upcoming company dates currently available for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW). Dividend data is not included in the latest data.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW) Stock FAQ

Data-supported answers about Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Weak
Current financial-health read

A reliable fair value estimate is not currently available for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW) is November 2, 2026.

The current market capitalization listed for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 is 4.21 B.

The ticker symbol for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 is NASDAQ-CORZW, and the stock is listed on NASDAQ.

Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 (NASDAQ-CORZW) is listed on NASDAQ.

The free float listed for Core Scientific Tranche 1 Equity Warrants Exp 23 Jan 2027 is 91.1%. Free float helps investors understand how much of the share base is available for public trading.

Similar Software Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

MSFT NASDAQ Microsoft Corporation Fair Value Fair Market Cap 3,895.2 B
PLTR NASDAQ Palantir Technologies Inc Fair Value Overvalued Market Cap 472.8 B
ORCL NYSE Oracle Corporation Fair Value Undervalued Market Cap 382.5 B
PANW NASDAQ Palo Alto Networks Inc Fair Value Overvalued Market Cap 311.3 B
SAP NYSE SAP SE ADR Fair Value Fair Market Cap 277 B
CRWD NASDAQ CrowdStrike Holdings Inc Fair Value Overvalued Market Cap 264.3 B
CRM NYSE Salesforce Inc Fair Value Undervalued Market Cap 204.6 B
NOW NYSE ServiceNow Inc Fair Value Fair Market Cap 164.3 B
FTNT NASDAQ Fortinet Inc Fair Value Overvalued Market Cap 132.1 B
ADBE NASDAQ Adobe Systems Incorporated Fair Value Bargain Market Cap 102.7 B
DDOG NASDAQ Datadog Inc Fair Value Overvalued Market Cap 96.825 B
INTU NASDAQ Intuit Inc Fair Value Bargain Market Cap 91.766 B
CDNS NASDAQ Cadence Design Systems Inc Fair Value Fair Market Cap 87.159 B
APP NASDAQ Applovin Corp Fair Value Undervalued Market Cap 87.093 B
SNPS NASDAQ Synopsys Inc Fair Value Fair Market Cap 82.431 B
TEAM NASDAQ Atlassian Corp Plc Fair Value Fair Market Cap 57.617 B
MSTR NASDAQ Strategy Inc Fair Value Fair Market Cap 56.101 B
ADSK NASDAQ Autodesk Inc Fair Value Undervalued Market Cap 52.711 B
WDAY NASDAQ Workday Inc Fair Value Undervalued Market Cap 50.608 B
NBIS NASDAQ Nebius Group NV Fair Value Fair Market Cap 43.51 B